Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jan 30.
Published in final edited form as: Behav Brain Res. 2017 Sep 28;337:61–69. doi: 10.1016/j.bbr.2017.09.043

Functional Coding Variation in the Presynaptic Dopamine Transporter Associated with Neuropsychiatric Disorders Drives Enhanced Motivation and Context-Dependent Impulsivity in Mice

Gwynne L Davis 1,2, Adele Stewart 1,2,3, Gregg D Stanwood 4, Raajaram Gowrishankar 1,2, Maureen K Hahn 1,2,3, Randy D Blakely 1,2,3
PMCID: PMC5645257  NIHMSID: NIHMS911481  PMID: 28964912

Abstract

Recent genetic analyses have provided evidence that clinical commonalities associated with different psychiatric diagnoses often have shared mechanistic underpinnings. The development of animal models expressing functional genetic variation attributed to multiple disorders offers a salient opportunity to capture molecular, circuit and behavioral alterations underlying this hypothesis. In keeping with studies suggesting dopaminergic contributions to attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BPD) and autism spectrum disorder (ASD), subjects with these diagnoses have been found to express a rare, functional coding substitution in the dopamine (DA) transporter (DAT), Ala559Val. We developed DAT Val559 knock-in mice, as a construct valid model of dopaminergic alterations that drive multiple clinical phenotypes, and here evaluate the impact of lifelong expression of the variant on impulsivity and motivation, utilizing the 5-choice serial reaction time task (5-CSRTT) and Go/NoGo as well as tests of time estimation (peak interval analysis), reward salience (sucrose preference), and motivation (progressive ratio test). Our findings indicate that the DAT Val559 variant induces impulsivity behaviors that are dependent upon the reward context, with increased impulsive action observed when mice are required to delay responding for a reward, whereas mice are able to withhold responding if there is a probability of reward for a correct rejection. Utilizing peak interval and progressive ratio tests, we provide evidence that impulsivity is likely driven by an enhanced motivational phenotype that also may drive faster task acquisition in operant tasks. These data provide critical validation that DAT, and more generally, DA signaling perturbations can drive impulsivity that can manifest in specific contexts and not others, and may rely on motivational alterations which may also drive increased maladaptive reward seeking.

Keywords: Attention-Deficit Hyperactivity Disorder, Motivation, Impulsivity, Dopamine Transporter, Transgenic Model, Instrumental Learning

1. INTRODUCTION

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most prevalent neurobehavioral disorder of childhood, affecting approximately 4–12% of school-aged children in the United States13 and risk for ADHD has been found to be significantly heritable1. Consistent with these findings, polymorphisms in DA system genes, including those encoding dopamine (DA) receptors48, DA metabolizing enzymes9, 10 and the DA transporter (DAT1114) have been associated with ADHD. In a search for functional coding variation in human DAT, we identified a Val substitution at Ala559 in two male siblings with ADHD15, 16, a variation that had been previously identified in a female with Bipolar Disorder (BPD)17. Subsequently, the Val559 substitution was found in two unrelated male subjects with autism spectrum disorder (ASD)18. In studies examining functional alterations in transfected cells, the DAT Val559 variant failed to impact DA recognition or uptake, but instead, promoted DAT-dependent DA efflux15, which we hypothesized could establish tonically-elevated, extracellular DA levels in vivo and “short-circuit” vesicular DA release mechanisms. Our subsequent studies with DAT Val559 knock-in mice bore out both of these predictions, as in vivo microdialysis studies demonstrated elevated extrasynaptic DA levels and ex vivo slice studies revealed tonic activation of presynaptic D2 DA autoreceptors (D2ARs) leading to blunted depolarization-induced vesicular DA release19.

The availability of DAT Val559 mice represents a key opportunity to evaluate molecular, cellular and circuit level perturbations underlying the behavioral changes in ADHD through studies of a construct-valid animal model. In our initial studies19, 20, we demonstrated that DAT Val559 mice display a stress-dependent hyperactivity (darting), as well as altered rearing behavior. More conspicuous was a blunting of locomotor and rearing enhancements produced by the psychostimulants used to treat ADHD, D-amphetamine and methylphenidate. Here, we extend these analyses to evaluate whether the DAT Val559 variant induces cognitive changes, with a particular focus on impulsivity, given the presence of the trait in our two ADHD probands as well as the maternal grandmother16. Through the use of complementary operant tasks, we were able to evaluate different facets of impulsivity as well as look at other behavioral perturbations associated with both the DA system and ADHD that could contribute to impulsive phenotypes, such as the ability to time events and reward valuation and motivation. We discuss our findings in the context of a model whereby DAT Val559 dependent DA efflux and tonic elevations in extracellular DA drive schedule-dependent impulsivity that may be driven by an enhanced motivational state for predictable rewards.

2. METHODS

2.1 Animals

All experiments were performed under a protocol approved by the Institutional Animal Care and Use Committees at Vanderbilt University and Florida Atlantic University. Homozygous DAT Val559 and wildtype (WT) littermate mice used in the study were bred from heterozygous breeders on the hybrid background used in our prior studies19 (75% 129S6 and 25% C57BL/6J). Males were evaluated in the present study owing to the bias toward male subjects for ADHD diagnoses21. Animals were housed on a 12:12 (L:D) cycle. Mice were tested during their active cycle, achieved by either raising animals on a reverse light cycle with lights on and off at 3 pm and 3 am, respectively, or by raising mice on a normal light cycle, with lights on and off at 7 am and 7 pm and then with transferal of mice to the reverse light cycle at 5 weeks of age, after weaning. Mice were approximately 6–7 weeks old when training for different behavioral assays commenced. For all operant conditioning tasks mice were placed on food restriction one week prior to the start of training. Mice were brought to approximately 85%–90% of their baseline weight (weighed every other day). On the fourth and fifth days (still under food restriction), mice were exposed to 33% Vanilla Ensure Original, the reward used for all the operant tasks, for one hour in the home cage. All operant tasks were performed under red light with operant chambers housed in sound attenuation boxes. All tests were conducted with chamber houselights turned off, unless specifically stated otherwise.

2.2 5-Choice Serial Reaction Time Task (5-CSRTT)

The 5 choice serial reaction time task (5-CSRTT) was utilized as it allows for a variety of traits to be measured including gross attention impairments (omissions), impulsivity issues (premature responses and preservative responses), and sustained attention (accuracy). Additionally, acquisition time of the task can be used as an indication of learning deficits that could result from difficulties in the above measures. 5-CSRTT performance can also be aligned with measures gathered from the continuous performance test, a common task used to assess and diagnose children with ADHD22, 23. We implemented the 5-CSRTT using Bussey-Saksida Mouse Touch Screen Chambers (Lafayette, IN) with a mask forming five 4 cm × 4 cm square touch zones arranged horizontally. All testing occurred under red light. It should be noted that for both 5-CSRTT and Go/NoGo (section 2.3) illumination of touch zones was performed with 100% illumination levels. See Supplemental Figure 1 for training schematic and paradigm diagram. During the Habituation phase of training, mice were exposed to the testing chamber for 30 min during which a 30 μl liquid reward was delivered every 10 sec coinciding with illumination of the reward receptacle. The 10 sec reward delivery timer was reset by head entry into the reward receptacle. Mice had to collect 30 rewards on two consecutive days to move to the Initial Touch phase of training. During the Initial Touch phase of training, one of the five touch zones was randomly illuminated for a 30 sec interval. Mice received reward regardless of touching the screen but received 3X reward if touch occurred during illumination, accompanied by a tone and illumination of reward receptacle. Mice had to collect 30 rewards in 30 min in order to move on to the Must Touch phase of training. During the Must Touch phase, single touch panels were illuminated pseudo-randomly (could not appear in the same location more than 3X consecutively) in one of the five locations. Illumination remained on until the correct location was touched. Blank touches (unlit locations) were not punished. Upon touching an illuminated panel, reward was delivered with concurrent tone and illumination of the reward receptacle. Upon head entry to receive reward, a five sec inter-trial interval (ITI) was initiated, followed by touch zone illumination to restart a trial. Mice had to collect 30 rewards in 60 min to move on to the Must Initiate phase of training. In the Must Initiate Phase, the session was initiated with delivery of a free reward. Once the reward was collected, a single touch zone was illuminated. Upon touch of this panel, reward was delivered concurrently with tone and reward receptacle illumination, followed by a 5 sec ITI. At this point, the reward receptacle was re-illuminated and mice were required to make a head entry into the reward receptacle to initiate a trial, at which time a single touch zone was illuminated to repeat the process. Mice had to collect 30 rewards in 60 min to move on to the Punish Incorrect phase.

In the Punish Incorrect phase, touch of an incorrect panel during stimulus presentation resulted in the stimulus being immediately turned off and the chamber being fully illuminated for a five sec time out. Subsequently, a five sec ITI was imposed before the receptacle light came on again for the initiation of a new trial. Mice had to complete 30 trials in 30 min at an accuracy of 80% correct before they could move on to the 5-choice evaluation phase. It is important to note that a hybrid advancement method24 was used to progress mice through the different training phases, such that mice who reached the punish incorrect phase the fastest were then rested at that stage. Occasionally, additional training sessions were performed to ensure that these mice remained at criterion, though done sparingly to limit over-training effects. Once all mice successfully completed the punish incorrect phase, they were moved as a group to the 5-choice phase. During the 5-choice phase, mice learned to respond to the illuminated zone with a progressively shorter stimulus presentation duration (16s, 8s, 4s, and 2s). Mice had to initiate the trial and wait through a 5 sec delay before presentation of the stimulus. Responses had to occur either within the stimulus presentation or within a 5 sec window post-stimulus presentation (limited hold). Mice received a 5 sec timeout with the house light on if they responded during the 5 sec delay (before stimulus presentation but after trial initiation), made an incorrect response, or omitted a response (no response within stimulus duration plus 5 sec limited hold). If mice made a premature response the trial was reset. Mice were required to complete 80 trials in 60 min with at least 80% accuracy and less than 20% omissions for two days in a row before being moved to a shorter stimulus duration of the training series. All mice were brought to a baseline performance which consisted of trial initiation, 5 sec delay, 2 sec stimulus presentation, 5 sec limited hold (7 sec to make a response), reward delivery, and a 5 sec ITI. Once this was reached, the delay component of the task was manipulated to further explore impulsivity. A long delay session was performed in which the mice had to wait 15 sec between trial initiation and onset of stimulus. A separate set of trials was implemented where a 2, 5, 10, and 15 sec delays were intermixed randomly (20 trials of each). Measures collected for this assay included % correct, % omission, number of premature responses, number of perseverative responses, and session length.

2.3 Go/NoGo Task

As a secondary measure to look at a different aspect of impulsivity, we used the Go/No-Go task. This assay is distinct from the impulsivity measures obtained in the 5-CSRTT in that Go/No-Go requires the mouse to learn to distinguish different signals associated with operant response and behavioral restraint in order to obtain a reward, making it a measure of motor inhibition/suppression versus a measure of waiting capabilities2527. Mice were initially trained in the same manner as they were for 5-CSRTT up through the Punish Incorrect phase (section 2.2), except mice had two larger (7.6 cm × 7 cm) touchscreen windows to interact with instead of five. Once mice completed the Punish Incorrect phase they were initially moved directly into Go/NoGo (60 trials, 20% No-Go trials). However, this was changed to Go-only trials upon failure of mice to complete the number of required trials and inability to acquire the No-Go behavior. Go-only trials consisted of trial initiation, 5 sec delay, and then the presentation of the stimulus in one of the two touchscreen windows for 3 sec with a 5 sec limited hold. The No-Go signal involved having both touchscreen windows lighting up together. Sessions consisted of 30 trials within 30 min. Mice received 8 training sessions on Go-only and were then moved to Go/NoGo, where mice were required to complete 30 trials within 30 min with 50% of the trials being No-Go trials. Mice were trained on Go/NoGo until stable performance rates were achieved (13 days). Mice were then tested in a single session where the delay between trial initiation and stimulus presentation was extended from 5 to 15 secs. The main dependent measures were omissions, premature responses, and correct rejections during No-Go trials (mice withheld responding).

2.4 Peak Interval Task

To evaluate the ability of mice to estimate time as one possible explanation for impulsivity, we implemented a Peak Interval Task. Animals were tested in Med-Associates (St. Albans, VT) operant chambers housed in sound attenuation boxes. For the first 2 days of training, mice were presented with a free reward and given 5 sec to consume the reward upon head entry. Reward was then presented every 10 sec after reward consumption, unless a nose-poke was made in any of the 3 nose-poke holes (backlit by LEDs), which elicited reward delivery (a Fixed Ratio 1-Fixed Time 10 secs schedule; FR1-FT10). Sessions lasted 30 min and mice could earn up to 30 rewards. Days 3 and 4 utilized an FR1-FT30 schedule. On day 5, mice were moved to continuous reinforcement. Under this protocol only the center back nose-poke hole was lit and mice had to nose-poke to get a reward. Mice were given 60 min to obtain 30 rewards. Once all mice could collect 30 rewards within 60 min, they were moved to either a fixed interval schedule of 5 sec or 15 sec. Importantly, mice that reached criterion for CRF at a faster pace were rested to prevent over-training, and then once all mice reached CRF criterion they were run for additional sessions as a group and then moved to a fixed interval schedule. The center nose-poke would illuminate, but it was only the first nose-poke after 5 or 15 sec of illumination that was rewarded. A 10 sec limited hold from the fixed interval mark was used. If mice made a nose-poke within that time, the nose-poke light went off, a click sounded, and the dipper was brought up. If no response was made within the limited hold, the nose-poke light went off and an omission was counted. Mice had 5 sec to consume the reward upon head entry into dipper. Trials were separated by a variable ITI that averaged 11 sec between reward collection or response omission and center nose-poke re-illumination. Mice were trained on FI 5 sec or FI 15 sec until their response latencies stabilized. Mice were then moved as a group to Peak Interval testing. This task functioned very similarly to Fixed Interval except with the addition of probe trials. During the probe trial, the nose-poke hole was lit for 3X the length of the fixed interval time, however, nose-poke responses produced no reward, allowing for a response curve to be recorded. Gaussian curves generated from the responses in the probe trials were used to provide information on interval timing variability (peak spread), maximum response rate (peak height), and timing accuracy (x-axis location of peak).

2.5 Progressive Ratio

To evaluate motivation for reward, mice underwent 2 days of habituation to operant chambers with dipper training. Every 3 min of a 30 min session, mice received a free reward, but were able to obtain reward sooner with a nose-poke into the center hole opposite the dipper. The dipper remained raised until mice made a head entry into the food receptacle, and then animals had 10 sec to consume the reward. Mice were then moved to a continuous reinforcement (CRF) paradigm, where a nose-poke to the center hole on the opposite wall of the food receptacle was required for a reward. Nose-poke holes were also located to the left and right of the food receptacle and were used to measure non-specific nose-poke activity. Mice were required to make 50 corrects responses in 45 min, and given 10 sec to drink their reward. After 2 consecutive days of successful completion, mice were trained for an additional week (6–7 training sessions) at 50 correct responses in 45 minutes, with 5 sec to drink their rewards. Mice were then run through a progressive ratio schedule as a group, requiring an increasing number of nose-pokes to obtain a reward. Sessions were ended after 60 min had elapsed or if the mouse was inactive for 5 minutes, whichever came first. Several measurements related to motivation are recorded, including the break point (the nose-poke requirement at which the mouse gives up), value met (last successful round of nose-pokes met before the mouse gives up), response rate, number of correct responses made, and number of rewards earned.

2.6 Sucrose Preference Test

To assess reward salience, we subjected mice to the Sucrose Preference test, singly housing mice with access to two bottles filled with water for a 2 day habituation, followed by substitution of water in 1 bottle with a 1% sucrose solution. On day 5, the sucrose solution was increased to 3%. Bottles were weighed daily and switched in placement. Sucrose consumption was calculated as the amount of sucrose solution consumed divided by total liquid consumption.

2.7 Statistical Analyses

Statistical analyses was done using GraphPad Prism 7 software package. Statistical significance was set at P ˂ 0.05 for all experimental results. The type of statistical analysis used was determined independently for each experiment and is listed in the relevant figure caption. Outlier analysis was performed using the ROUT method with the false discovery rate set at 2%.

3. RESULTS

3.1 DAT Val559 mice acquire 5-CSRTT faster than WT littermates

To explore multiple cognitive capacities, as well as impulsivity, of the DAT Val559 mice, we first evaluated their performance on the 5-CSRTT. During task acquisition (9 Phases), we observed no deficits in task acquisition compared to WT littermates (Figure 1A; WT n=18, VaL559, n=19). Instead, DAT Val559 mice progressed more quickly through both the early training phases (habituation-punish incorrect) and during the stimulus reduction phases than WT animals. Although accuracy assessed in the full 5-CSRTT was largely equivalent, we detected a difference on day 1 of testing (16 sec stimulus duration), which may also suggest that retention of the rules of the test were more effectively stored or retrieved in DAT Val559 mice (Figure 1B).

Figure 1. DAT VAL559 mice show alterations in 5-CSRTT acquisition and impulsivity.

Figure 1

(A)DAT Val559 mice learn 5-choice serial reaction time task (5-CSRTT) faster than their WT littermate counterparts. (WT, n=18; VaL559, n=19; Two-Way RM-ANOVA, time P ˂ 0.0001, interaction P ˂ 0.0001, genotype P < 0.01; post-hoc tests reveal P ˂ 0.05 at day 6 and 27, P ˂ 0.01 at day 9 and 26, and P ˂ 0.0001 at Day 7 and 8). (B) DAT Val559, similar to their faster acquisition of the task, also display better accuracy on the 5-choice task on their first day experience of the full paradigm at a 16 sec stimulus duration (Two-Way RM-ANOVA, Time P ˂ 0.05, interaction P ˂ 0.0001, genotype P < 0.05; post-hoc tests reveal P ˂ 0.01 at day 1 16 sec) (C) No genotype differences were observed for premature responses working down to and at baseline (WT, n=18; VaL559, n=19; Two-Way RM-ANOVA). (D) DAT Val559 mice display a higher impulsivity than WT mice when the delay between the start of a trial and stimulus presentation is increased from 5 sec to 15 sec (two-tailed Student’s t-test, premature responses P < 0.05 (WT. n=15; VaL559, n=19). (E) DAT Val559 mice display reduced impulsivity compared to WT mice when the delay between the start of a trial and stimulus presentation is variable/unpredictable (two-tailed Student’s t-test, premature responses P <0.05 (WT, n=15; Val559 = 19). (F) Additionally, when premature responses were separated out based on the delay duration, DAT Val559 mice specifically show a reduction at the 15 sec duration (delay P ˂ 0.0001, genotype P <0.05, interaction P < 0.05; post-hoc reveals a genotype difference at the 15 sec delay, P ˂ 0.01).

3.2 DAT Val559 mice demonstrate waiting-dependent impulsivity in 5-CSRTT

Impulsivity can be assessed in the 5-CSRTT during training as well as when temporal variables are manipulated following training28, 29. DAT Val559 mice exhibited no differences in premature responses compared to WT during training (Figure 1C), nor did they differ in other baseline performance measures (e.g. perseverative responses, % omissions, activity, and session length; Supplemental Figure 2A–D). Importantly, we observed no genotype difference in activity levels, as measured by beam breaks (Supplemental Figure 2C), an important consideration as both hyper- and hypo- locomotive behaviors could confound additional measures collected. Notably, when the delay between trial initiation and stimulus presentation was extended from the 5 sec delay used during training to a 15 sec delay, we detected a significant increase in premature responses in DAT Val559 mice (Figure 1D; WT n=15, VaL559, n=19), indicative of a waiting impulsivity25. Interestingly, when multiple delay times (2, 5, 10, and 15 secs) were randomized and delivered across a session, preventing a predictable use of time as a preparatory cue, DAT Val559 mice displayed fewer premature responses than WT animals (Figure 1E). When responses were analyzed for each of the delay values used, a trend was observed across all the tests, reaching statistical significance at the 15 sec delay (Figure 1F).

3.3 DAT Val559 mice display normal interval timing capacity with an increased response rate with increased waiting load

We hypothesized that the waiting impulsivity of DAT Val559 in the long delay condition in 5-CSRTT could be driven by a faster internal clock for interval timing. Agents and mutations that impact DA signaling, and DAT specifically3033, have been demonstrated to impact interval timing, the ability of animals to accurately report time between cue onset and an imposed response delay. To look at the ability to time intervals we implemented the Peak Interval paradigm (Figure 2A). We observed no significant difference between the estimated peak for delay timing whether at 5 sec or 15 sec between the DAT Val559 and WT littermates (Figure 2B and 2C; WT, n=10 and 9 respectively, VAL559, n=10 and 10 respectively). However, at the 15 sec interval DAT VAL559 demonstrated a significantly elevated response rate (Figure 2C).

Figure 2. DAT Val559 mice have normal interval timing, but heightened response rates with longer wait times.

Figure 2

(A) Training schematic for Peak Interval task. Mice were trained on a fixed interval of 5 sec or 15 sec (WT, n=10 and 9 per training group, VAL559, n=10 per training group). Mice were then tested on a probe trial for accuracy of response timing. (B) Both WT and VAL559 mice display the same response curves at the 5 sec timing (Two-Way RM-ANOVA; interaction P > 0.05, time P > 0.05, genotype P > 0.05). (C) However when the interval is increased to 15 sec, DAT Val559 display an increase in response rate amplitude (Two-Way RM ANOVA; interaction P ˂ 0.0001, time P ˂ 0.0001, genotype P =0.0557).

3.4 Alterations in Go/NoGo reveal that DAT Val559 mice can withhold responding when a withheld response has a probability of being rewarded

Given our findings related to impulsivity in the 5-CSRTT, we decided to utilize another test commonly implemented to assess this trait, the Go/NoGo paradigm. In this test, we detected a difference in acquisition of the task with DAT Val559 progressing through habituation to the punish incorrect phase faster (Figure 3A; WT, n=8, Val559, n=12), though for this task this effect predominantly seems to be driven by differences in task performance on stage 1 (Supplemental Figure 3A & 3B). During the Go/NoGo sessions, when examined across sessions, DAT Val559 and WT mice initially demonstrated an equal percentage of omissions. By session 8, however, DAT Val559 mice demonstrated significantly more omissions than WT animals (Figure 3B). Increased omissions did not reflect an inferior recognition of the rules of the test as DAT Val559 were able to withhold responding during NoGo trials just as well as WT animals, if not better, as reflected by session correct rejections (Figure 3C). Moreover, no significant differences were detected across days for premature responding (Figure 3D). Next, in a single session, we extended the delay between trial initiation to stimulus presentation from 5 sec to 15 sec. This alteration produced no significant differences in percent omissions (Figure 3E). However, as with their superior performance during training, DAT Val559 mice made significantly more correct rejections than WT animals (Figure 3F) in the absence of significant premature responses (Figure 3G).

Figure 3. DAT Val559 mice show alterations in the Go/NoGo task.

Figure 3

(A) DAT Val559 mice acquire the Go/NoGo task differently than WT (WT, n=8, Val559, n=12; Two-Way RM-ANOVA, genotype P < 0.05, day P < 0.0001, interaction P < 0.05). (B) DAT Val559 mice progressively make more omissions (Two-Way RM-ANOVA, genotype P < 0.05, day P < 0.0001, interaction P < 0.05; post-hoc tests reveal P < 0.05 at day 8). (C) DAT Val559 mice trend towards making more correct rejections than WT (Two-Way RM-ANOVA, genotype P = 0.07, day P < 0.0001, interaction P > 0.05). (D) No difference was seen in premature responses between genotypes (Two-Way RM-ANOVA, Two-Way RM-ANOVA; interaction P > 0.05, time P > 0.05, genotype P > 0.05). (E) No genotype difference was present in percent omissions during long delay (two-tailed Student’s t-test, P > 0.05). (F) DAT Val559 mice made more correct rejections during long delay (two-tailed Student’s t-test, P < 0.05). (G) No genotype difference was seen in premature responses during long delay (two-tailed Student’s t-test, P > 0.05).

3.5 DAT Val559 mice have enhanced motivation

In prior studies, an increased response rate in the interval timing paradigm has been has been associated with increased motivation3437. To assess motivation more directly, we tested DAT Val559 and WT littermates for their willingness to sustain responses despite increasing demand, as assessed in the Progressive Ratio (PR) Test. Here, DAT Val559 mice exhibited clear evidence of enhanced motivation for reward, demonstrating a significantly increased average PR break point (Figure 4A; WT n = 22, VaL559 n = 21), greater PR value met (Figure 4B), increased correct responses (Figure 4C), greater number of rewards collected (Figure 4D), and overall a significantly higher response rate (Figure 4E). No differences were detected in total number of head entries made, number of incorrect responses made, or total experimental session time (Supplemental Figure 4A–C). Importantly, there was no difference in sucrose preference (Figure 4F, n = 8 per genotype), indicating that the changes detected in motivational measures in the PR test are likely not driven by a change in reward preference.

Figure 4. DAT Val559 mice have enhanced motivation as seen in progressive ratio without alterations in sucrose preference.

Figure 4

(A) DAT Val559 mice display a higher break point in the Progressive Ratio (PR) task compared to WT (two-tailed Student’s t-test, PR Break P < 0.04 (WT, n = 22; VaL559; n = 21)) and (B) PR met (P < 0.05). (C) DAT Val559 made more correct responses (P < 0.05) and (D) received more rewards (P < 0.05). (E) Higher response rates were also seen (P < 0.05). (F) Sucrose preference was calculated showing no statistical difference between genotype (Two-Way RM ANOVA; P > 0.05; n = 8 per genotype).

4. DISCUSSION

Multiple rodent models have been advanced to gain insights into the mechanisms driving traits associated with ADHD38, 39, including models featuring a disruption of DA signaling. Recently, we introduced the DAT Val559 mouse model as a construct valid model of disorders with DAergic dysfunction19, 20. Although ADHD was the pathophysiological focus that lead to our identification of the DAT Val559 variant, the mutation has been found in a female with BPD17, as well as two unrelated males with ASD18. Notably, ADHD is more prevalent in relatives of BPD subjects40 and many individuals diagnosed with ASD meet clinical criteria for ADHD41, 42, suggesting that the DAT Val559 mice may be most properly considered to model DAergic alterations that can lead to distinct clinical trajectories depending on interacting genetic and environmental factors. While impulsivity is one of the core components of an ADHD diagnosis, and is present in both ASD and BPD, the source of that impulsivity and the type of impulsivity can vary greatly43. Understanding the underlying driving force of impulsivity can guide future circuit-based evaluations of mechanism and possibly assist in the development of better treatments. Behavioral inhibition deficits can be categorized and tested for in a number of ways43. One such type is impulsive action of pre-potent motor responses, which results in premature responding during a task that requires a set wait time before the motor response is appropriate (i.e. difficulty waiting). Here, we demonstrate that DAT Val559 have a waiting impulsivity, driven by a heightened motivational state.

Owing to elevated impulsivity traits in our two DAT Val559 expressing probands, as well as the maternal transmitting grandmother16, we initiated our testing efforts with the 5-CSRTT, a test that can reveal impairments in behavior ascribed to facets of attention, learning and impulsivity23, 24, 44. DAT Val559 mice demonstrated no deficiencies in learning the 5-CSRTT. Indeed, these animals reached task criteria during training more rapidly than their WT littermates. Although initially surprising, these findings may relate to studies in humans reporting a stronger association of DAT polymorphisms with impulsivity versus inattention45, as well as brain activity linked to inhibitory response control versus attentional orienting46. When DAT Val559 mice were challenged to withhold responses for three times the length of the fixed delay imposed during training (5s to 15s), they demonstrated significant premature actions, suggestive of impulsivity. Interestingly, when tested with a variable delay, DAT Val559 animals demonstrated reduced premature responses that became increasingly evident as the delay was extended, demonstrating a differential effect of timing context on impulsive responding. These results are interesting with respect to recent findings that performance of subjects with ADHD is context dependent, being diminished relative to controls when simple two choice tests are used, versus a more complex five choice option47. Additionally, studies done in amphetamine-treated rats have shown a connection between training context and waiting, such that performance improves on a response inhibition timing task in a variable timing climate, compared to an increase in premature responses when treated rats are tested in a fixed timing climate32. As DAT Val559 induces a state of chronic increased extracellular DA, we hypothesized that the DAT Val559 mice use timing cues differently.

Given the 5-CSRTT randomized delay paradigm may prevent mice from using interval time as a cue of when to expect the stimulus, we hypothesized, that increased premature responses by the DAT Val559 mice in the long delay paradigm may reflect perturbed time-estimation, underlying the appearance of impulsivity versus deficits in response inhibition per se. In support of this idea, significant evidence supports a contribution of DA signaling in interval timing30, 4853. For example, normal human subjects given amphetamine exhibit an increase in perceived elapsed time33. These and other findings have led to suggestions that disruptions in the ability to perceive time intervals (e.g. sped up internal clocks and/or increased clock variability) may represent an ADHD endophenotype5458. However, DAT knockdown mice demonstrate an ability to estimate elapsed time correctly in the peak interval task, though they initiate responding sooner than WT animals and display a general increase in overall response rate35. To investigate this issue, we examined DAT Val559 mice and their WT littermates in the peak interval task, training mice to report the elapse of 5 or 15 secs, recapitulating the times used in 5-CSRTT. If time estimation was contributing to the differences observed in the 5-CSRTT, we hypothesized that we would observe genotype differences with the 15, but not the 5 sec interval, manifested as a leftward shift in the peak interval response curve of DAT Val559 mice. Instead, we failed to observe a genotype effect on time estimation at either time point, but instead detected an increase in response amplitude for the 15 sec interval by the DAT Val559 mice versus WT animals.

Increased response amplitude in the peak interval task has been suggested to reflect increased motivation35, 49. Additionally, DA signaling has been directly implicated in response rate in the peak interval task, as overexpression of the DA D2 receptors (D2Rs) selectively in striatal medium spiny neurons delays the onset of response initiation and reduces response rates in the peak interval task37, 59. Interestingly, the early start of response and the overall heightened responses seen in the peak interval task with DAT knockdown mice can be normalized by low doses of raclopride, a D2R antagonist, in a range thought to predominantly impact D2ARs35. This is an intriguing with respect to the DAT Val559 model, as D2ARs are both constitutively activated by tonic DAT Val559-mediated DA efflux15 and drive efflux60. Our ongoing studies seek to determine whether all, or subsets of DAergic projections are equivalently influenced in the DATVal559 model by functional and/or structural D2R/DAT interactions. In this regard, we previously documented D2AR-mediated physiological changes in substantia nigra DA neurons of DAT Val559 mice19, suggesting a reasonable orientation toward dorsal striatum.

Our peak interval studies indicate that DAT Val559 mice exhibit impulsive action when required to wait if trained on a fixed, predictable timing delay, independent of the ability of the animals to estimate elapsed time. This waiting impulsivity does not reflect blanket deficits in pre-potent motor inhibition as assessed in the Go/NoGo test. Thus, DAT Val559 mice had no trouble withholding behavioral responses on NoGo trials. In fact, as mice progressed through sequential sessions, we found that DAT Val559 mice actually trend towards being better at correct rejections than their WT littermates. Intriguingly, this performance appears to come at the cost of an increase in percentage of omitted responses, in contrast to the lack of a genotype difference in omissions in 5-CSRTT. Moreover, unlike our findings with the 5-CSRTT, we observed no increase in measures of impulsivity in Go/NoGo test when the delay before stimulus presentation was increased from 5 to 15 secs. In fact, the DAT Val559 mice made significantly more correct rejections than WT, arguing for better inhibitory control. These findings can be reconciled if the DAT Val559 variant instills an increased motivation/anticipatory drive rather than a frank deficit in motor inhibition. It may be that different motivational and/or response inhibition demands of the two tasks contribute to the distinct phenotypes of DAT Val559 mice on each task. Our studies of DAT Val559 mice in the progressive ratio task supports this idea, where increased motivation is suggested by a significant increase in break point, an increased number of values met before reaching a break point, an increased number of correct responses made and rewards earned, and a significant overall increase in response rate, relative to WT littermates.

We do not believe that this enhanced motivation is driven by a general increased hedonic value of rewards as no genotype differences were observed in sucrose consumption in the two-bottle choice test. Instead, we suspect that the increased willingness of DAT Val559 mice to expend effort for reward indicates an intrinsically elevated drive for reward. In contrast, DAT KO mice show a very strong increased sucrose preference that increases with exposure61, but do not show the same increase in motivational indices of progressive ratio tests62. These findings presumably reflect the differences in the genetic insult driving increased extracellular DA in the DAT Val559 model vs the DAT KO (e.g. DA leak versus constitutive loss of DA uptake) and the degree to which different DAergic pathways rely on the transporter to maintain extracellular and intracellular DA homeostasis.

Enhanced motivation for rewards in the DAT Val559 mice is at first blush difficult to align with reports of reduced reward motivation in ADHD subjects63, 64, or reports of a lack of perturbed motivation altogether65. Certainly, ADHD is not a homogeneous disorder and subjects with and without motivational changes likely arise from the distinct etiological mechanisms. Studies with construct-valid models such as the DAT Val559 mouse may thus assist in the dissection of subgroups defined not by overt behavioral categories but by underlying pathophysiology. In this regard, prior studies have demonstrated that increased levels of extracellular DA increase both motivation and risky/impulsive behaviors66, 67. Motivational changes may also be reward-specific, accommodating reduced, normal or even elevated motivation for some rewards but not others68. It has been argued that although intrinsic motivation may be low in ADHD subjects, they are more positively affected by the promise of an immediate extrinsic reward, leading to greater improvements in task performance compared to non-ADHD children6971. Thus, children with ADHD can improve their performance in measures such as error monitoring relative to their age-matched controls, in the context of specific extrinsic motivational conditions (i.e. performing a task for money or gifts rather than praise or a letter grade)69. Additionally, receipt of rewards appears able to normalize impulsivity tendencies, suggesting a significant intersection between motivational and impulse control circuits72, 73. An enhanced motivational drive for reward could also explain the increased performance of DAT Val559 mice in the Go/NoGo test where the mutants may be more motivated by the 50% chance of receiving a reward through behavioral inhibition, as compared to WT animals, yielding higher instances of correct rejections and low premature responses.

It seems reasonable to propose that the increased speed in task acquisition in both 5-CSRTT and the Go/NoGo task is driven by the increased motivation of the DAT Val559 mice. This idea nicely dovetails with the Reinforcement Sensitivity Theory from the human literature in ADHD, specifically the Behavioral Approach System (BAS), which hypothesizes that high BAS traits and resultant impulsivity are driven by an increased motivation for reward74, 75. A high BAS trait index would be expected to allow for increased sensitivity to response-based reward and faster establishment between instrumental learning and reward, similar to the increased acquisition seen in the DAT Val559 with 5-CSRTT. Imaging studies involving BAS-related tasks have implicated several brain regions heavily involved in DA signaling including the dorsal and ventral striatum and orbital frontal cortices74. Furthermore, children and adults with ADHD, specifically of the hyperactive/impulsive subtype, score higher on traits of BAS and display increased behavioral approach tendencies to reward associated tasks76, 77, bringing to mind the premature responses seen with the increased delay in 5-CRTT and the increased response rate in the peak interval task in DAT Val559 mice.

The idea that impulsivity in the clinical context may be for some subjects, at its core, a disorder of dysregulated motivation is important for the development of both behavioral and pharmacological interventions for disorders involving DA dysfunction including ADHD. Finally, given that the DAT Val559 variant has been identified in BPD and ASD, studies with the mouse model affords a unique opportunity to examine how various genetic and environmental factors shape the different clinical presentations that arise with changes arising from singular insults in DAergic signaling.

5. CONCLUSION

In conclusion, our studies reveal that DAT Val559 mice display several behavioral phenotypes with direct relevance to ADHD symptomology. As such, our work offers potential insights into the contribution that heritable alterations in DAT expression and function make to the pathophysiology of neurodevelopmental disorders. Our work predicts that molecular changes that impact tonic extracellular DA levels can enhance motivation for reward, which can emerge phenotypically as elevated impulsivity, effects separate from perturbations of intrinsic time estimation or deficits in attention. DAT Val559 mice may therefore prove useful as a construct valid model with which to elaborate the circuitry and signaling disruptions that drive clinical syndromes characterized by impulsivity as well as their treatment.

Supplementary Material

1
2
3
4

HIGHLIGHTS.

  • DAT Val559 mouse a relevant model for understanding ADHD and related disorders

  • Model shows alterations in motivation, cognition, and impulsivity

  • Impulsivity driven by increased reward motivation and changes with reward context

Acknowledgments

We wish to acknowledge the expert lab support of Christina Svitek, Jane Wright, Tracey Moore-Jarrett, Qiao Han, Angela Steele, and Matthew Gross. We would also like to thank Randy Barrett and John Allison of the Vanderbilt Neurobehavioral Core for assistance with behavioral testing, and Peter Griffin for assistance with data analysis. GLD is a Ph.D. candidate of the Vanderbilt Neuroscience Graduate Program. Financial support for the studies derives from an Elaine Sanders-Bush Scholar’s Award from the Vanderbilt Silvio O. Conte Center for Neuroscience Research (GLD) and NIH awards MH107132 (GLD) and MH105094 (RDB).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–248. doi: 10.1016/S0140-6736(05)66915-2. [DOI] [PubMed] [Google Scholar]
  • 2.Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. The American journal of psychiatry. 2007;164(6):942–948. doi: 10.1176/ajp.2007.164.6.942. [DOI] [PubMed] [Google Scholar]
  • 3.Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2012;9(3):490–499. doi: 10.1007/s13311-012-0135-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wu J, Xiao H, Sun H, Zou L, Zhu LQ. Role of dopamine receptors in ADHD: a systematic meta-analysis. Molecular neurobiology. 2012;45(3):605–620. doi: 10.1007/s12035-012-8278-5. [DOI] [PubMed] [Google Scholar]
  • 5.Swanson J, Oosterlaan J, Murias M, Schuck S, Flodman P, Spence MA, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(9):4754–4759. doi: 10.1073/pnas.080070897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gilsbach S, Neufang S, Scherag S, Vloet TD, Fink GR, Herpertz-Dahlmann B, et al. Effects of the DRD4 genotype on neural networks associated with executive functions in children and adolescents. Developmental cognitive neuroscience. 2012;2(4):417–427. doi: 10.1016/j.dcn.2012.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ribases M, Ramos-Quiroga JA, Hervas A, Sanchez-Mora C, Bosch R, Bielsa A, et al. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2012;13(4):281–292. doi: 10.3109/15622975.2011.584905. [DOI] [PubMed] [Google Scholar]
  • 8.Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) Human molecular genetics. 2006;15(14):2276–2284. doi: 10.1093/hmg/ddl152. [DOI] [PubMed] [Google Scholar]
  • 9.Matthews N, Vance A, Cummins TD, Wagner J, Connolly A, Yamada J, et al. The COMT Val158 allele is associated with impaired delayed-match-to-sample performance in ADHD. Behavioral and brain functions : BBF. 2012;8:25. doi: 10.1186/1744-9081-8-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J. DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2010;35(12):2414–2426. doi: 10.1038/npp.2010.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mazei-Robison MS, Blakely RD. ADHD and the Dopamine Transporter: Are There Reasons to Pay Attention? In: Sitte H, Freissmuth M, editors. Handbook of Experimental Pharmacology. Vol. 175. Springer; 2006. pp. 373–415. [DOI] [PubMed] [Google Scholar]
  • 12.Cook EH, Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, et al. Association of attention-deficit disorder and the dopamine transporter gene. American journal of human genetics. 1995;56(4):993–998. [PMC free article] [PubMed] [Google Scholar]
  • 13.Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2007;144b(4):541–550. doi: 10.1002/ajmg.b.30453. [DOI] [PubMed] [Google Scholar]
  • 14.Mill J, Xu X, Ronald A, Curran S, Price T, Knight J, et al. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2005;133b(1):68–73. doi: 10.1002/ajmg.b.30107. [DOI] [PubMed] [Google Scholar]
  • 15.Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, et al. Anomalous dopamine release associated with a human dopamine transporter coding variant. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2008;28(28):7040–7046. doi: 10.1523/JNEUROSCI.0473-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology. 2005;49(6):724–736. doi: 10.1016/j.neuropharm.2005.08.003. [DOI] [PubMed] [Google Scholar]
  • 17.Horschitz S, Hummerich R, Lau T, Rietschel M, Schloss P. A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression. Molecular psychiatry. 2005;10(12):1104–1109. doi: 10.1038/sj.mp.4001730. [DOI] [PubMed] [Google Scholar]
  • 18.Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Molecular psychiatry. 2013;18(12):1315–1323. doi: 10.1038/mp.2013.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, et al. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(44):E4779–4788. doi: 10.1073/pnas.1417294111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, et al. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder. Neurochemistry International. 2014;73:56–70. doi: 10.1016/j.neuint.2013.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Getahun D, Jacobsen SJ, Fassett MJ, Chen W, Demissie K, Rhoads GG. Recent trends in childhood attention-deficit/hyperactivity disorder. JAMA pediatrics. 2013;167(3):282–288. doi: 10.1001/2013.jamapediatrics.401. [DOI] [PubMed] [Google Scholar]
  • 22.Bari A, Dalley JW, Robbins TW. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nature protocols. 2008;3(5):759–767. doi: 10.1038/nprot.2008.41. [DOI] [PubMed] [Google Scholar]
  • 23.Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002;163(3–4):362–380. doi: 10.1007/s00213-002-1154-7. [DOI] [PubMed] [Google Scholar]
  • 24.Mar AC, Horner AE, Nilsson SR, Alsio J, Kent BA, Kim CH, et al. The touchscreen operant platform for assessing executive function in rats and mice. Nature protocols. 2013;8(10):1985–2005. doi: 10.1038/nprot.2013.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Robinson ESJ, Eagle DM, Economidou D, Theobald DEH, Mar AC, Murphy ER, et al. Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: Specific deficits in ‘waiting’ versus ‘stopping’. Behavioural Brain Research. 2009;196(2):310–316. doi: 10.1016/j.bbr.2008.09.021. [DOI] [PubMed] [Google Scholar]
  • 26.Bari A, Robbins TW. Inhibition and impulsivity: Behavioral and neural basis of response control. Progress in neurobiology. 2013 doi: 10.1016/j.pneurobio.2013.06.005. [DOI] [PubMed] [Google Scholar]
  • 27.Dalley JW, Mar AC, Economidou D, Robbins TW. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacology, biochemistry, and behavior. 2008;90(2):250–260. doi: 10.1016/j.pbb.2007.12.021. [DOI] [PubMed] [Google Scholar]
  • 28.Yan TC, Dudley JA, Weir RK, Grabowska EM, Pena-Oliver Y, Ripley TL, et al. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day. PloS one. 2011;6(3):e17586. doi: 10.1371/journal.pone.0017586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Oliver YP, Ripley TL, Stephens DN. Ethanol effects on impulsivity in two mouse strains: similarities to diazepam and ketamine. Psychopharmacology. 2009;204(4):679–692. doi: 10.1007/s00213-009-1500-0. [DOI] [PubMed] [Google Scholar]
  • 30.Bussi IL, Levín G, Golombek DA, Agostino PV. Involvement of dopamine signaling in the circadian modulation of interval timing. European Journal of Neuroscience. 2014;40(1):2299–2310. doi: 10.1111/ejn.12569. [DOI] [PubMed] [Google Scholar]
  • 31.Cheng R-K, MacDonald CJ, Meck WH. Differential effects of cocaine and ketamine on time estimation: Implications for neurobiological models of interval timing. Pharmacology Biochemistry and Behavior. 2006;85(1):114–122. doi: 10.1016/j.pbb.2006.07.019. [DOI] [PubMed] [Google Scholar]
  • 32.Hayton SJ, Maracle AC, Olmstead MC. Opposite Effects of Amphetamine on Impulsive Action with Fixed and Variable Delays to Respond. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2012;37(3):651–659. doi: 10.1038/npp.2011.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lake JI, Meck WH. Differential effects of amphetamine and haloperidol on temporal reproduction: Dopaminergic regulation of attention and clock speed. Neuropsychologia. 2013;51(2):284–292. doi: 10.1016/j.neuropsychologia.2012.09.014. [DOI] [PubMed] [Google Scholar]
  • 34.Balci F, Ludvig E, Gibson J, Allen B, Frank K, Kapustinski B, et al. Pharmacological manipulations of interval timing using the peak procedure in male C3H mice. Psychopharmacology. 2008;201(1):67–80. doi: 10.1007/s00213-008-1248-y. [DOI] [PubMed] [Google Scholar]
  • 35.Balci F, Ludvig EA, Abner R, Zhuang X, Poon P, Brunner D. Motivational effects on interval timing in dopamine transporter (DAT) knockdown mice. Brain Research. 2010;1325:89–99. doi: 10.1016/j.brainres.2010.02.034. [DOI] [PubMed] [Google Scholar]
  • 36.MacDonald CJ, Cheng R-K, Meck WH. Acquisition of “Start” and “Stop” response thresholds in peak-interval timing is differentially sensitive to protein synthesis inhibition in the dorsal and ventral striatum. Frontiers in Integrative Neuroscience. 2012;6:10. doi: 10.3389/fnint.2012.00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ward RD, Kellendonk C, Simpson EH, Lipatova O, Drew MR, Fairhurst S, et al. Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behavioral neuroscience. 2009;123(4):720–730. doi: 10.1037/a0016503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.van der Kooij MA, Glennon JC. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neuroscience and biobehavioral reviews. 2007;31(4):597–618. doi: 10.1016/j.neubiorev.2006.12.002. [DOI] [PubMed] [Google Scholar]
  • 39.Gainetdinov RR. Strengths and limitations of genetic models of ADHD. Attention deficit and hyperactivity disorders. 2010;2(1):21–30. doi: 10.1007/s12402-010-0021-3. [DOI] [PubMed] [Google Scholar]
  • 40.Faraone SV, Biederman J, Wozniak J. Examining the Comorbidity Between Attention Deficit Hyperactivity Disorder and Bipolar I Disorder: A Meta-Analysis of Family Genetic Studies. American Journal of Psychiatry. 2012;169(12):1256–1266. doi: 10.1176/appi.ajp.2012.12010087. [DOI] [PubMed] [Google Scholar]
  • 41.Berenguer-Forner C, Miranda-Casas A, Pastor-Cerezuela G, Rosello-Miranda R. Comorbidity of autism spectrum disorder and attention deficit with hyperactivity A review study. Revista de neurologia. 2015;60(Suppl 1):S37–43. [PubMed] [Google Scholar]
  • 42.Taurines R, Schwenck C, Westerwald E, Sachse M, Siniatchkin M, Freitag C. ADHD and autism: differential diagnosis or overlapping traits? A selective review Attention deficit and hyperactivity disorders. 2012;4(3):115–139. doi: 10.1007/s12402-012-0086-2. [DOI] [PubMed] [Google Scholar]
  • 43.Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends in Cognitive Sciences. 2012;16(1):81–91. doi: 10.1016/j.tics.2011.11.009. [DOI] [PubMed] [Google Scholar]
  • 44.McTighe SM, Neal SJ, Lin Q, Hughes ZA, Smith DG. The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex. PloS one. 2013;8(4):e62189. doi: 10.1371/journal.pone.0062189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gizer IR, Waldman ID. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4) Journal of abnormal psychology. 2012;121(4):1011–1023. doi: 10.1037/a0028225. [DOI] [PubMed] [Google Scholar]
  • 46.Albrecht B, Brandeis D, Uebel-von Sandersleben H, Valko L, Heinrich H, Xu X, et al. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1. Journal of child psychology and psychiatry, and allied disciplines. 2014;55(8):914–923. doi: 10.1111/jcpp.12212. [DOI] [PubMed] [Google Scholar]
  • 47.Patros CH, Alderson RM, Lea SE, Tarle SJ. Context influences decision-making in boys with attention-deficit/hyperactivity disorder: A comparison of traditional and novel choice-impulsivity paradigms. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 2017;23(2):242–254. doi: 10.1080/09297049.2015.1119261. [DOI] [PubMed] [Google Scholar]
  • 48.Daw ND, Courville AC, Touretzky DS. Representation and Timing in Theories of the Dopamine System. Neural Computation. 2006;18(7):1637–1677. doi: 10.1162/neco.2006.18.7.1637. [DOI] [PubMed] [Google Scholar]
  • 49.Meck WH. Neuroanatomical localization of an internal clock: A functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems. Brain Research. 2006;1109(1):93–107. doi: 10.1016/j.brainres.2006.06.031. [DOI] [PubMed] [Google Scholar]
  • 50.Oprisan SA, Buhusi CV. Modeling Pharmacological Clock and Memory Patterns of Interval Timing in a Striatal Beat-Frequency Model with Realistic, Noisy Neurons. Frontiers in Integrative Neuroscience. 2011;5:52. doi: 10.3389/fnint.2011.00052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Parker KL, Chen K-H, Kingyon JR, Cavanagh JF, Narayanan NS. D1-Dependent 4 Hz Oscillations and Ramping Activity in Rodent Medial Frontal Cortex during Interval Timing. The Journal of Neuroscience. 2014;34(50):16774–16783. doi: 10.1523/JNEUROSCI.2772-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Pine A, Shiner T, Seymour B, Dolan RJ. Dopamine, time, and impulsivity in humans. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30(26):8888–8896. doi: 10.1523/JNEUROSCI.6028-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Rivest F, Kalaska J, Bengio Y. Alternative time representation in dopamine models. J Comput Neurosci. 2010;28(1):107–130. doi: 10.1007/s10827-009-0191-1. [DOI] [PubMed] [Google Scholar]
  • 54.Hart H, Marquand AF, Smith A, Cubillo A, Simmons A, Brammer M, et al. Predictive neurofunctional markers of attention-deficit/hyperactivity disorder based on pattern classification of temporal processing. Journal of the American Academy of Child and Adolescent Psychiatry. 2014;53(5):569–578 e561. doi: 10.1016/j.jaac.2013.12.024. [DOI] [PubMed] [Google Scholar]
  • 55.Himpel S, Banaschewski T, Gruttner A, Becker A, Heise A, Uebel H, et al. Duration discrimination in the range of milliseconds and seconds in children with ADHD and their unaffected siblings. Psychological medicine. 2009;39(10):1745–1751. doi: 10.1017/S003329170900542X. [DOI] [PubMed] [Google Scholar]
  • 56.Hwang SL, Gau SS, Hsu WY, Wu YY. Deficits in interval timing measured by the dual-task paradigm among children and adolescents with attention-deficit/hyperactivity disorder. Journal of child psychology and psychiatry, and allied disciplines. 2010;51(3):223–232. doi: 10.1111/j.1469-7610.2009.02163.x. [DOI] [PubMed] [Google Scholar]
  • 57.Hwang-Gu SL, Gau SS. Interval timing deficits assessed by time reproduction dual tasks as cognitive endophenotypes for attention-deficit/hyperactivity disorder. PloS one. 2015;10(5):e0127157. doi: 10.1371/journal.pone.0127157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Luman M, Oosterlaan J, Sergeant JA. Modulation of response timing in ADHD, effects of reinforcement valence and magnitude. Journal of abnormal child psychology. 2008;36(3):445–456. doi: 10.1007/s10802-007-9190-8. [DOI] [PubMed] [Google Scholar]
  • 59.Drew MR, Simpson EH, Kellendonk C, Herzberg WG, Lipatova O, Fairhurst S, et al. Transient Overexpression of Striatal D2 Receptors Impairs Operant Motivation and Interval Timing. The Journal of Neuroscience. 2007;27(29):7731–7739. doi: 10.1523/JNEUROSCI.1736-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, et al. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30(17):6048–6057. doi: 10.1523/JNEUROSCI.5094-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Costa RM, Gutierrez R, De Araujo IE, Coelho MRP, Kloth AD, Gainetdinov RR, et al. Dopamine levels modulate the updating of tastant values. Genes, Brain and Behavior. 2007;6(4):314–320. doi: 10.1111/j.1601-183X.2006.00257.x. [DOI] [PubMed] [Google Scholar]
  • 62.Hironaka N, Ikeda K, Sora I, Uhl GR, Niki H. Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Annals of the New York Academy of Sciences. 2004;1025:140–145. doi: 10.1196/annals.1316.018. [DOI] [PubMed] [Google Scholar]
  • 63.Metin B, Tas ZC, Cebi M, Buyukaslan A, Soysal A, Hatiloglu D, et al. Reward Processing Deficits During a Spatial Attention Task in Patients With ADHD: An fMRI Study. Journal of attention disorders. 2017 doi: 10.1177/1087054717703188. 1087054717703188. [DOI] [PubMed] [Google Scholar]
  • 64.Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular psychiatry. 2011;16(11):1147–1154. doi: 10.1038/mp.2010.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Demurie E, Roeyers H, Wiersema JR, Sonuga-Barke E. No Evidence for Inhibitory Deficits or Altered Reward Processing in ADHD: Data From a New Integrated Monetary Incentive Delay Go/No-Go Task. Journal of attention disorders. 2016;20(4):353–367. doi: 10.1177/1087054712473179. [DOI] [PubMed] [Google Scholar]
  • 66.Cagniard B, Balsam PD, Brunner D, Zhuang X. Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2006;31(7):1362–1370. doi: 10.1038/sj.npp.1300966. [DOI] [PubMed] [Google Scholar]
  • 67.St Onge JR, Ahn S, Phillips AG, Floresco SB. Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2012;32(47):16880–16891. doi: 10.1523/JNEUROSCI.3807-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Morsink S, Sonuga-Barke E, Mies G, Glorie N, Lemiere J, Van der Oord S, et al. What motivates individuals with ADHD? A qualitative analysis from the adolescent’s point of view. European child & adolescent psychiatry. 2017 doi: 10.1007/s00787-017-0961-7. [DOI] [PubMed] [Google Scholar]
  • 69.Fosco WD, Hawk LW, Jr, Rosch KS, Bubnik MG. Evaluating cognitive and motivational accounts of greater reinforcement effects among children with attention-deficit/hyperactivity disorder. Behavioral and brain functions : BBF. 2015;11:20. doi: 10.1186/s12993-015-0065-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Groom MJ, Liddle EB, Scerif G, Liddle PF, Batty MJ, Liotti M, et al. Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 2013;54(8):836–845. doi: 10.1111/jcpp.12069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Holroyd CB, Baker TE, Kerns KA, Muller U. Electrophysiological evidence of atypical motivation and reward processing in children with attention-deficit hyperactivity disorder. Neuropsychologia. 2008;46(8):2234–2242. doi: 10.1016/j.neuropsychologia.2008.02.011. [DOI] [PubMed] [Google Scholar]
  • 72.Ma I, van Duijvenvoorde A, Scheres A. The interaction between reinforcement and inhibitory control in ADHD: A review and research guidelines. Clinical psychology review. 2016;44:94–111. doi: 10.1016/j.cpr.2016.01.001. [DOI] [PubMed] [Google Scholar]
  • 73.Herrera PM, Speranza M, Hampshire A, Bekinschtein TA. Monetary rewards modulate inhibitory control. Frontiers in human neuroscience. 2014;8:257. doi: 10.3389/fnhum.2014.00257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Costumero V, Barros-Loscertales A, Fuentes P, Rosell-Negre P, Bustamante JC, Avila C. BAS-drive trait modulates dorsomedial striatum activity during reward response-outcome associations. Brain imaging and behavior. 2016;10(3):869–879. doi: 10.1007/s11682-015-9466-5. [DOI] [PubMed] [Google Scholar]
  • 75.Corr PJ. Reinforcement sensitivity theory and personality. Neuroscience & Biobehavioral Reviews. 2004;28(3):317–332. doi: 10.1016/j.neubiorev.2004.01.005. [DOI] [PubMed] [Google Scholar]
  • 76.Mitchell JT, Robertson CD, Kimbrel NA, Nelson-Gray RO. An Evaluation of Behavioral Approach in Adults with ADHD. Journal of Psychopathology and Behavioral Assessment. 2011;33(4):430. [Google Scholar]
  • 77.Mitchell JT. Behavioral approach in ADHD: testing a motivational dysfunction hypothesis. Journal of attention disorders. 2010;13(6):609–617. doi: 10.1177/1087054709332409. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2
3
4

RESOURCES